MassMutual Private Wealth & Trust’s Procept Biorobotics PRCT Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.48K	Buy	191 +101	+112%	+$2.01K	﹤0.01%	1753
2026 Q2	$2.03K	Sell	90 -210	-70%	-$5.26K	﹤0.01%	2004
2026 Q1	$7.5K	Buy	+300	New	+$8.45K	﹤0.01%	1503
2025 Q2	–	Sell	-30	Closed	-$1.75K	–	2466
2025 Q1	$1.75K	Sell	30 -73	-71%	-$4.98K	﹤0.01%	1957
2024 Q4	$8.29K	Buy	+103	New	+$8.8K	﹤0.01%	1330
2023 Q4	–	Sell	-19	Closed	-$623	–	2059
2023 Q3	$623	Buy	19 +11	+138%	+$375	﹤0.01%	1776
2023 Q2	$283	Buy	+8	New	+$265	﹤0.01%	1848

Other funds holding PRCT

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return

Bastion Asset Management Montreal, Canada $229M AUM 5.92% 1-Year Est. Return

C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Granite Investment Partners El Segundo, California $1.84B AUM 35.93% 1-Year Est. Return

MassMutual Private Wealth & Trust's PRCT Position: Q3 2026 in Review

MassMutual Private Wealth & Trust increased its Procept Biorobotics (PRCT) stake by 112% in Q3 2026, buying an estimated $2.01K and bringing the position to 191 shares worth $3.48K. The position accounts for ﹤0.01% of the portfolio, ranked #1753.

MassMutual Private Wealth & Trust first reported a position in PRCT in Q2 2023 and has held it in 7 quarters since. The position peaked at $8.29K in Q4 2024. 89 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.

MassMutual Private Wealth & Trust held 191 shares of Procept Biorobotics worth $3.48K as of Q3 2026.
MassMutual Private Wealth & Trust bought 101 Procept Biorobotics shares in Q3 2026, an estimated $2.01K.
Procept Biorobotics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1753 holding.
MassMutual Private Wealth & Trust first reported a position in Procept Biorobotics in Q2 2023 and has held it in 7 quarters since.
MassMutual Private Wealth & Trust's Procept Biorobotics position peaked at $8.29K in Q4 2024.
89 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.